Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Jan 2010 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Axis Large Cap Fund |
|---|---|
| 07 Jan 2010 | ₹100.00 |
| 28 May 2011 | ₹104.96 |
| 15 Oct 2012 | ₹113.39 |
| 04 Mar 2014 | ₹133.73 |
| 23 Jul 2015 | ₹198.41 |
| 10 Dec 2016 | ₹186.61 |
| 30 Apr 2018 | ₹261.11 |
| 17 Sep 2019 | ₹285.12 |
| 04 Feb 2021 | ₹392.66 |
| 25 Jun 2022 | ₹388.79 |
| 13 Nov 2023 | ₹460.62 |
| 01 Apr 2025 | ₹559.42 |
| 20 Aug 2026 | ₹605.36 |
| Metric | Axis · Regular NAV ₹61.02 Very High risk ★★★☆☆ | Category median Large Cap Fund · 35 funds |
|---|---|---|
| -0.18% | -0.15% | |
| +10.41% | +11.26% | |
| +6.74% | +9.97% | |
| +11.64% | +11.47% | |
| +11.45% | +11.40% | |
| +7.45% | — | |
| +13.22% | +13.21% | |
| +13.36% | +12.15% | |
| +13.22% | +12.34% | |
| Risk | ||
| 12.62% | 13.29% | |
| 0.31 | 0.34 | |
| 0.43 | 0.47 | |
| -30.18% | -36.99% | |
| Nifty 100 | — | |
| +0.55% | +1.29% | |
| 0.90 | 0.96 | |
| 93.5% | 101.0% | |
| 87.5% | 93.9% | |
| 1.77% | 2.19% | |
| ₹30,395Cr | ₹2,004Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 23% | 44% | |
| Shreyash Devalkar · 9.7y | — | |
| 07 Jan 2010 | — | |
| 44 | — | |
| 49.3% | — | |
| -1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.